{"disease":{"id":"desmoid-tumors-aggressive-fibromatosis","name":"desmoid tumors aggressive fibromatosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01981551","title":"Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}